Keywords: kos, files, niaspan, uk, pharmaceuticals, usa, filed
Kos Files For Niaspan In UK
Article | 16 July 1998
Kos Pharmaceuticals of the USA has filed for approval to marketNiaspan, its proprietary extended-release formulation of the lipid-lowering drug niacin, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
